Evry
France
64
2024-12-12
53
2025-07-08
These are the the leading inventors for applications assigned to GENETHON:
GENETHON based in Evry, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
FLUIDIC SYSTEM FOR PRODUCING EXTRACELLULAR VESICLES AND RELATED METHOD
#2 | 2024-09-26Hybrid Recombinant Adeno-Associated Virus Serotype Between AAV9 and AAVrh74 with Reduced Liver Tropism
#3 | 2023-11-23 ✅ Patent 12,351,816 granted on 2025-07-08CNS GENE DELIVERY USING PERIPHERAL ADMINISTRATION OF AAV VECTORS
#4 | 2022-09-01 ✅ Patent 12,305,187 granted on 2025-05-20Acid-alpha glucosidase variants and uses thereof
#5 | 2021-11-11 ✅ Patent 12,171,843 granted on 2024-12-24Hybrid regulatory elements
#6 | 2021-11-04 ✅ Patent 11,596,698 granted on 2023-03-07Synthetic polynucleotides encoding a human FKRP protein
#7 | 2021-07-01Use of Syncytin for Targeting Drug and Gene Delivery to Lung Tissue
#8 | 2021-05-06 ✅ Patent 11,427,836 granted on 2022-08-30Method for reducing the expression of NKCC1 in a subject
#9 | 2021-04-15 ✅ Patent 12,037,362 granted on 2024-07-16Hybrid recombinant adeno-associated virus serotype between AAV9 and AAVrh74 with reduced liver tropism
#10 | 2021-04-01 ✅ Patent 11,499,154 granted on 2022-11-15Antisense targeting dynamin 2 and use for the treatment of centronuclear myopathies and neuropathies
#11 | 2021-03-04 ✅ Patent 11,298,348 granted on 2022-04-12Combination treatment of sarcoglycanopathies
#12 | 2020-12-31 ✅ Patent 12,023,366 granted on 2024-07-02Efficient systemic treatment of dystrophic muscle pathologies
#13 | 2020-12-10 ✅ Patent 12,098,355 granted on 2024-09-24Fluid system for producing extracellular vesicles and related method
#14 | 2020-09-17 ✅ Patent 11,492,621 granted on 2022-11-08Methods for the treatment of Leber congenital amaurosis
#15 | 2020-09-17 ✅ Patent 11,541,131 granted on 2023-01-03Treatment of glycogen storage disease III
#16 | 2020-08-20Use of a Syncytin for Targeting Drug and Gene Delivery to Regenerate Muscle Tissue
#17 | 2020-05-07 ✅ Patent 11,427,824 granted on 2022-08-30Compositions and methods for the treatment of myotonic dystrophy
#18 | 2020-03-05 ✅ Patent 11,376,321 granted on 2022-07-05Method for removing anti-AAV antibodies from a blood-derived composition
#19 | 2020-01-09 ✅ Patent 11,767,538 granted on 2023-09-26Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
#20 | 2020-01-02 ✅ Patent 11,236,307 granted on 2022-02-01Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
#21 | 2019-12-26 ✅ Patent 11,339,406 granted on 2022-05-24Acid-alpha glucosidase variants and uses thereof
#22 | 2019-12-26 ✅ Patent 11,421,211 granted on 2022-08-23Acid-alpha glucosidase variants and uses thereof
#23 | 2019-06-06 ✅ Patent 10,786,546 granted on 2020-09-29Efficient systemic treatment of dystrophic muscle pathologies
#24 | 2018-12-27 ✅ Patent 10,736,945 granted on 2020-08-11Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)
#25 | 2018-12-20 ✅ Patent 10,752,898 granted on 2020-08-25Effective gene therapy tools for dystrophin exon 53 skipping
#26 | 2018-11-08 ✅ Patent 11,371,061 granted on 2022-06-28Compositions and methods for improving viral vector efficiency
#27 | 2018-10-25 ✅ Patent 10,767,192 granted on 2020-09-08Baculovirus system for the expression of a gene therapy vector
#28 | 2018-09-13 ✅ Patent 11,819,478 granted on 2023-11-21Selective gene therapy expression system
#29 | 2018-05-10 ✅ Patent 10,428,315 granted on 2019-10-01Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
#30 | 2018-04-12 ✅ Patent 11,104,897 granted on 2021-08-31Compositions and methods for the treatment of nucleotide repeat expansion disorders
#31 | 2018-03-08WIDESPREAD GENE DELIVERY TO MOTOR NEURONS USING PERIPHERAL INJECTION OF AAV VECTORS
#32 | 2018-01-18 ✅ Patent 10,597,654 granted on 2020-03-24Methods for the treatment of Leber congenital amaurosis
#33 | 2017-06-08 ✅ Patent 10,166,272 granted on 2019-01-01Efficient systemic treatment of dystrophic muscle pathologies
#34 | 2017-04-27 ✅ Patent 9,895,426 granted on 2018-02-20Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)
#35 | 2017-04-06 ✅ Patent 9,839,677 granted on 2017-12-12Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)
#36 | 2017-02-16 ✅ Patent 9,777,272 granted on 2017-10-03Methods for the treatment of Leber congenital amaurosis
#37 | 2017-02-02 ✅ Patent 10,471,132 granted on 2019-11-12Treatment of hyperbilirubinemia
#38 | 2017-01-05 ✅ Patent 10,465,169 granted on 2019-11-05Method for purifying enveloped viruses or viral vectors
#39 | 2016-11-17 ✅ Patent 11,099,193 granted on 2021-08-24Methods for diagnosing or monitoring muscular dystrophies
#40 | 2016-08-11 ✅ Patent 10,125,352 granted on 2018-11-13Method for producing enveloped viruses
#41 | 2016-03-03 ✅ Patent 9,981,049 granted on 2018-05-29Selective gene therapy expression system
#42 | 2015-09-17 ✅ Patent 9,415,120 granted on 2016-08-16Systemic gene replacement therapy for treatment of X-linked MyoTubular Myopathy (XLMTM)
#43 | 2015-09-10 ✅ Patent 9,862,934 granted on 2018-01-09Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
#44 | 2015-08-27 ✅ Patent 9,933,438 granted on 2018-04-03Method for diagnosing muscular dystrophy
#45 | 2015-05-21 ✅ Patent 9,526,742 granted on 2016-12-27Use of epigenome-modifying compounds for the treatment of genetic muscular diseases linked to a protein-conformational disorder
#46 | 2015-04-23 ✅ Patent 9,487,782 granted on 2016-11-08Methods for the treatment of leber congenital amaurosis
#47 | 2014-12-04 ✅ Patent 10,480,010 granted on 2019-11-19Baculovirus expression systems
#48 | 2014-11-27 ✅ Patent 10,017,783 granted on 2018-07-10Baculovirus system for the expression of a gene therapy vector
#49 | 2014-09-11 ✅ Patent 10,596,264 granted on 2020-03-24Peptides with viral infection enhancing properties and their use
#50 | 2014-09-04 ✅ Patent 8,957,044 granted on 2015-02-17Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)
#51 | 2014-06-26 ✅ Patent 9,012,425 granted on 2015-04-21Methods for the treatment of Leber congenital amaurosis
#52 | 2013-07-25 ✅ Patent 9,546,112 granted on 2017-01-17Methods of increasing efficiency of vector penetration of target tissue
#53 | 2013-07-04CALPAIN-3 INHIBITORS FOR TREATING MUSCULAR DYSTROPHIES AND CARDIOMYOPATHIES
#54 | 2013-03-21ADENO-ASSOCIATED VIRAL VECTOR FOR EXON SKIPPING IN A GENE ENCODING A DISPENSIBLE-DOMAIN PROTEIN
#55 | 2013-02-07 ✅ Patent 8,673,935 granted on 2014-03-18Drugs for the treatment of sarcogylcanopathies
#56 | 2012-06-14 ✅ Patent 8,993,317 granted on 2015-03-31Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
#57 | 2012-06-07 ✅ Patent 9,114,161 granted on 2015-08-25Widespread gene delivery to the retina using systemic administration of AAV vectors
#58 | 2012-03-29Adeno-Associated Viral Vector for Exon Skipping in a Gene Encoding a Dispensable Domain Protein
#59 | 2010-10-21ADENO-ASSOCIATED VIRAL VECTORS FOR THE EXPRESSION OF DYSFERLIN
#60 | 2010-09-23 ✅ Patent 9,926,574 granted on 2018-03-27Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
#61 | 2010-05-27 ✅ Patent 10,208,318 granted on 2019-02-19CNS gene delivery using peripheral administration of AAV vectors
#62 | 2010-01-14 ✅ Patent 8,273,763 granted on 2012-09-25Drugs for the treatment of sarcoglycanopathies
#63 | 2009-09-03Specific CD4+CD25+ Regulatory T Cells for Haematopoietic Cell Transplantation and Immune Tolerance
#64 | 2006-11-16Use of sirnas for gene silencing in antigen presenting cells
Also check out GENETHON's (Evry, France) applicant profile with 44 patent applications submitted.
8397 ⎘